首页 > 最新文献

Blood pressure. Supplement最新文献

英文 中文
Epidemiology and prevention of arterial hypertension in Poland. 波兰动脉高血压的流行病学和预防。
Pub Date : 2005-12-01 DOI: 10.1080/08038020500429052
Tomasz Zdrojewski, Bogdan Wyrzykowski, Radosław Szczech, Lukasz Wierucki, Marek Naruszewicz, Krzysztof Narkiewicz, Marzena Zarzeczna-Baran

The authors review the present situation in epidemiology and prevention of arterial hypertension in Poland. In 2002, the NATPOL PLUS survey on representative sample of adults (n=3051, age range 18-93) was conducted. Prevalence of hypertension, diagnosed on basis of three separate visits, was 29%, awareness 67% and efficacy of treatment 12.5%. Thus, in Poland, one-third of 8.6 million hypertensives are unaware of their disease. A comparison with data from other countries should be careful due to the different methods (age range, number of readings and visits) used in the studies. The data, in concert with a decrease in awareness of one's own blood pressure (from 71% in 1994 to 59% in 2002), called for urgent preventive measures. Two large interventions were implemented under the National Programme POLKARD in 2003: the Polish 400 Cities Project aimed to increase detection and knowledge of hypertension and other risk factors among small-town and village communities, and the educational project, A Chance for the Young Heart targeted at children aged 11-14 years and using traditional teaching methods and an interactive Internet website. Also, an educational and marketing programme targeted at public opinion leaders and decision makers (trade unions, local governments, healthcare financing authorities, print media and radio, the Polish Parliament) started in 1999 and is still in process.

作者综述了波兰动脉高血压的流行病学和预防现状。2002年,对具有代表性的成人样本(n=3051,年龄在18-93岁之间)进行了NATPOL PLUS调查。根据三次单独就诊诊断出的高血压患病率为29%,知晓率为67%,治疗有效性为12.5%。因此,在波兰,860万高血压患者中有三分之一不知道自己的疾病。由于研究中使用了不同的方法(年龄范围、阅读次数和访问次数),因此与其他国家的数据进行比较应该谨慎。这些数据与人们对自身血压认识的下降(从1994年的71%降至2002年的59%)相一致,要求采取紧急预防措施。2003年,在国家POLKARD方案下实施了两项大型干预措施:波兰400个城市项目,目的是在小城镇和乡村社区中增加对高血压和其他危险因素的发现和了解;以及教育项目,“少年心脏的机会”,目标是11-14岁的儿童,使用传统教学方法和互动互联网网站。此外,一项针对舆论领袖和决策者(工会、地方政府、卫生保健筹资当局、印刷媒体和广播电台、波兰议会)的教育和营销方案于1999年启动,目前仍在进行中。
{"title":"Epidemiology and prevention of arterial hypertension in Poland.","authors":"Tomasz Zdrojewski,&nbsp;Bogdan Wyrzykowski,&nbsp;Radosław Szczech,&nbsp;Lukasz Wierucki,&nbsp;Marek Naruszewicz,&nbsp;Krzysztof Narkiewicz,&nbsp;Marzena Zarzeczna-Baran","doi":"10.1080/08038020500429052","DOIUrl":"https://doi.org/10.1080/08038020500429052","url":null,"abstract":"<p><p>The authors review the present situation in epidemiology and prevention of arterial hypertension in Poland. In 2002, the NATPOL PLUS survey on representative sample of adults (n=3051, age range 18-93) was conducted. Prevalence of hypertension, diagnosed on basis of three separate visits, was 29%, awareness 67% and efficacy of treatment 12.5%. Thus, in Poland, one-third of 8.6 million hypertensives are unaware of their disease. A comparison with data from other countries should be careful due to the different methods (age range, number of readings and visits) used in the studies. The data, in concert with a decrease in awareness of one's own blood pressure (from 71% in 1994 to 59% in 2002), called for urgent preventive measures. Two large interventions were implemented under the National Programme POLKARD in 2003: the Polish 400 Cities Project aimed to increase detection and knowledge of hypertension and other risk factors among small-town and village communities, and the educational project, A Chance for the Young Heart targeted at children aged 11-14 years and using traditional teaching methods and an interactive Internet website. Also, an educational and marketing programme targeted at public opinion leaders and decision makers (trade unions, local governments, healthcare financing authorities, print media and radio, the Polish Parliament) started in 1999 and is still in process.</p>","PeriodicalId":8974,"journal":{"name":"Blood pressure. Supplement","volume":"2 ","pages":"10-6"},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08038020500429052","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25814943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 64
Arterial hypertension as a public health issue in the Czech Republic. 作为捷克共和国公共卫生问题的动脉高血压。
Pub Date : 2005-12-01 DOI: 10.1080/08038020500429060
Renata Cífková

Hypertension increases the risk of coronary heart disease, stroke, peripheral arterial disease and heart failure. Five independent cross-sectional surveys for cardiovascular risk factors have been conducted in the Czech Republic (1985, 1988, 1992, 1997/98 and 2000/01), always involving a representative population sample aged 25-64 years. Over a period of 15-16 years, there was a statistically significant downward trend in population mean systolic (from 133.6 +/- 20.2 to 128.8 +/- 18.1 mmHg; p < 0.001) and diastolic (from 84.1 +/- 11.3 to 81.4 +/- 10.0 mmHg; p < 0.001) blood pressure (BP). There was also a significant decrease in the prevalence of hypertension in both sexes (from 51.9% to 45.6% in men; p < 0.001; from 42.5% to 33.0% in women; p < 0.001). Awareness of hypertension increased in both sexes, showing higher rates for females (men from 41.4% to 62.1%; p < 0.001; women from 58.9% to 73.8%; p < 0.001). Hypertension control improved significantly over the period of 15/16 years (from 3.9% to 17.9%; p < 0.001), consistently showing more effective control in women. The significant decrease in population mean BP seems to have contributed to the decrease in total and cardiovascular mortality in the Czech Republic observed since 1985.

高血压会增加患冠心病、中风、外周动脉疾病和心力衰竭的风险。在捷克共和国(1985年、1988年、1992年、1997/98年和2000/01年)进行了五次心血管危险因素的独立横断面调查,总是涉及年龄在25-64岁之间的代表性人群样本。在15-16年间,人口平均收缩压(从133.6 +/- 20.2降至128.8 +/- 18.1 mmHg;p < 0.001)和舒张压(从84.1 +/- 11.3到81.4 +/- 10.0 mmHg;p < 0.001)血压(BP)。男女高血压患病率也有显著下降(男性从51.9%降至45.6%;P < 0.001;女性从42.5%降至33.0%;P < 0.001)。男女对高血压的认识都有所增加,其中女性的高血压发病率更高(男性从41.4%上升到62.1%;P < 0.001;女性从58.9%降至73.8%;P < 0.001)。在15/16年期间,高血压控制显著改善(从3.9%到17.9%;P < 0.001),持续显示女性更有效的控制。人口平均血压的显著下降似乎有助于捷克共和国自1985年以来观察到的总死亡率和心血管死亡率的下降。
{"title":"Arterial hypertension as a public health issue in the Czech Republic.","authors":"Renata Cífková","doi":"10.1080/08038020500429060","DOIUrl":"https://doi.org/10.1080/08038020500429060","url":null,"abstract":"<p><p>Hypertension increases the risk of coronary heart disease, stroke, peripheral arterial disease and heart failure. Five independent cross-sectional surveys for cardiovascular risk factors have been conducted in the Czech Republic (1985, 1988, 1992, 1997/98 and 2000/01), always involving a representative population sample aged 25-64 years. Over a period of 15-16 years, there was a statistically significant downward trend in population mean systolic (from 133.6 +/- 20.2 to 128.8 +/- 18.1 mmHg; p < 0.001) and diastolic (from 84.1 +/- 11.3 to 81.4 +/- 10.0 mmHg; p < 0.001) blood pressure (BP). There was also a significant decrease in the prevalence of hypertension in both sexes (from 51.9% to 45.6% in men; p < 0.001; from 42.5% to 33.0% in women; p < 0.001). Awareness of hypertension increased in both sexes, showing higher rates for females (men from 41.4% to 62.1%; p < 0.001; women from 58.9% to 73.8%; p < 0.001). Hypertension control improved significantly over the period of 15/16 years (from 3.9% to 17.9%; p < 0.001), consistently showing more effective control in women. The significant decrease in population mean BP seems to have contributed to the decrease in total and cardiovascular mortality in the Czech Republic observed since 1985.</p>","PeriodicalId":8974,"journal":{"name":"Blood pressure. Supplement","volume":"2 ","pages":"25-8"},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08038020500429060","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25814840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Resistant hypertension. 抗高血压。
Pub Date : 2005-12-01 DOI: 10.1080/08038020500428989
Andrzej Tykarski

The incidence of resistant hypertension remains to be clarified. In this article, three categories of resistance are distinguished: resistant patient, resistant clinician and refractory hypertension. Inadequate compliance, which in case of antihypertensive treatment means taking fewer doses of medications than prescribed, remains a significant cause of poor blood pressure control. Among most frequent physician-related causes of resistant hypertension, there are measurement errors, pseudohypertension, white coat hypertension and therapy errors. Careful elimination of patient- and physician-related reasons of inadequate blood pressure control should lead to the diagnosis of truly resistant hypertension. One of the causes of refractory hypertension may be concomitant use of other medications that are known to reduce antihypertensive effect of main drugs. Resistance may be associated with increased intravascular volume or fluid overload or with sympathetic activation. Modifiable contributing factors responsible for resistant hypertension include obesity often coexisting with insulin resistance and metabolic syndrome as well as excessive alcohol use and cigarette smoking. Another potential cause of refractory hypertension is the presence of secondary hypertension. Certain therapeutic modifications are essential in resistant hypertension.

顽固性高血压的发病率尚不清楚。本文将耐药分为三类:耐药患者、耐药临床医师和难治性高血压。在降压治疗的情况下,依从性不足意味着服用的药物剂量少于处方,这仍然是血压控制不良的一个重要原因。在顽固性高血压最常见的医生相关原因中,有测量错误、假性高血压、白大褂高血压和治疗错误。仔细排除与患者和医生有关的血压控制不充分的原因,才能诊断出真正的顽固性高血压。难治性高血压的原因之一可能是同时使用其他已知会降低主要药物降压作用的药物。阻力可能与血管内容积增加或液体超载或交感神经激活有关。可改变的导致顽固性高血压的因素包括肥胖,通常与胰岛素抵抗和代谢综合征共存,以及过度饮酒和吸烟。难治性高血压的另一个潜在原因是继发性高血压。对顽固性高血压进行某些治疗调整是必要的。
{"title":"Resistant hypertension.","authors":"Andrzej Tykarski","doi":"10.1080/08038020500428989","DOIUrl":"https://doi.org/10.1080/08038020500428989","url":null,"abstract":"<p><p>The incidence of resistant hypertension remains to be clarified. In this article, three categories of resistance are distinguished: resistant patient, resistant clinician and refractory hypertension. Inadequate compliance, which in case of antihypertensive treatment means taking fewer doses of medications than prescribed, remains a significant cause of poor blood pressure control. Among most frequent physician-related causes of resistant hypertension, there are measurement errors, pseudohypertension, white coat hypertension and therapy errors. Careful elimination of patient- and physician-related reasons of inadequate blood pressure control should lead to the diagnosis of truly resistant hypertension. One of the causes of refractory hypertension may be concomitant use of other medications that are known to reduce antihypertensive effect of main drugs. Resistance may be associated with increased intravascular volume or fluid overload or with sympathetic activation. Modifiable contributing factors responsible for resistant hypertension include obesity often coexisting with insulin resistance and metabolic syndrome as well as excessive alcohol use and cigarette smoking. Another potential cause of refractory hypertension is the presence of secondary hypertension. Certain therapeutic modifications are essential in resistant hypertension.</p>","PeriodicalId":8974,"journal":{"name":"Blood pressure. Supplement","volume":"2 ","pages":"42-5"},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08038020500428989","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25814843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The challenge of blood pressure control in patients with ischaemic heart disease in Europe. 欧洲缺血性心脏病患者血压控制的挑战
Pub Date : 2005-12-01
Kalina Kawecka-Jaszcz, Piotr Jankowski, Andrzej Pajak, Danuta Czarnecka

The goal of the paper is to summarize the current status of blood pressure management in patients with ischaemic heart disease. Recently published results from Europe and North America showed that about half of ischaemic heart disease patients have their blood pressure over 140/90 mmHg. Moreover, these data provide further evidence that poor hypertension management is common in a variety of healthcare settings. Although most ischaemic heart disease patients receive blood pressure-lowering drugs, still a large proportion of them does not reach the recommended treatment goals. During recent years, several attempts were made to improve the control of risk factors (among them blood pressure) in patients with ischaemic heart disease; however, none of them was definitively successful.

本文的目的是总结缺血性心脏病患者血压管理的现状。欧洲和北美最近公布的结果显示,大约一半的缺血性心脏病患者血压超过140/90毫米汞柱。此外,这些数据提供了进一步的证据,表明高血压管理不善在各种医疗机构中都很常见。虽然大多数缺血性心脏病患者接受降压药治疗,但仍有很大一部分患者未达到推荐的治疗目标。近年来,为了改善对缺血性心脏病患者的危险因素(包括血压)的控制,进行了一些尝试;然而,没有一个是绝对成功的。
{"title":"The challenge of blood pressure control in patients with ischaemic heart disease in Europe.","authors":"Kalina Kawecka-Jaszcz,&nbsp;Piotr Jankowski,&nbsp;Andrzej Pajak,&nbsp;Danuta Czarnecka","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The goal of the paper is to summarize the current status of blood pressure management in patients with ischaemic heart disease. Recently published results from Europe and North America showed that about half of ischaemic heart disease patients have their blood pressure over 140/90 mmHg. Moreover, these data provide further evidence that poor hypertension management is common in a variety of healthcare settings. Although most ischaemic heart disease patients receive blood pressure-lowering drugs, still a large proportion of them does not reach the recommended treatment goals. During recent years, several attempts were made to improve the control of risk factors (among them blood pressure) in patients with ischaemic heart disease; however, none of them was definitively successful.</p>","PeriodicalId":8974,"journal":{"name":"Blood pressure. Supplement","volume":"2 ","pages":"6-9"},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25814941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A patient with high normal blood pressure--should we treat? 一个正常血压高的病人,我们应该治疗吗?
Pub Date : 2005-12-01 DOI: 10.1080/08038020500424715
Danuta Czarnecka, Grzegorz Bilo
Currently blood pressure (BP) is considered normal (for most subjects) if below 140 mmHg for systolic and 90 mmHg for diastolic BP. However, the risk of death displays an approximately linear relationship with BP levels below this cut‐off. Therefore more attention is now being paid to the portion of the population characterized by BP levels remaining within normal limits but approaching the 140/90 mmHg level. The 2003 ESH–ESC guidelines define BP between 130/85 and 139/89 mmHg as “high normal”, while the 2003 JNC7 guidelines introduced a new category of “prehypertension” (BP between 120/80 and 139/89 mmHg). Both these conditions affect a significant portion of a general population. Evidence is available that high normal BP is associated with an adverse risk profile and an increased risk of cardiovascular events. Therefore lifestyle changes are recommended in subjects belonging to this category and some trial data indicate that pharmacological treatment may be beneficial in high‐risk subjects with high normal BP levels. Strong evidence on the benefits of therapeutic intervention in this group is, however, still lacking.
目前血压(BP)如果低于140 mmHg的收缩压和90 mmHg的舒张压被认为是正常的(对大多数受试者来说)。然而,死亡风险与低于临界值的血压水平呈近似线性关系。因此,人们现在更多地关注那些血压水平保持在正常范围内但接近140/90 mmHg水平的人群。2003年的ESH-ESC指南将血压在130/85和139/89 mmHg之间定义为“高正常”,而2003年的JNC7指南引入了一个新的类别“高血压前期”(血压在120/80和139/89 mmHg之间)。这两种情况都会影响很大一部分人群。有证据表明,高正常血压与不良风险状况和心血管事件风险增加有关。因此,建议这类患者改变生活方式,一些试验数据表明,药物治疗可能对血压正常偏高的高危患者有益。然而,关于治疗干预对这一群体的益处的有力证据仍然缺乏。
{"title":"A patient with high normal blood pressure--should we treat?","authors":"Danuta Czarnecka,&nbsp;Grzegorz Bilo","doi":"10.1080/08038020500424715","DOIUrl":"https://doi.org/10.1080/08038020500424715","url":null,"abstract":"Currently blood pressure (BP) is considered normal (for most subjects) if below 140 mmHg for systolic and 90 mmHg for diastolic BP. However, the risk of death displays an approximately linear relationship with BP levels below this cut‐off. Therefore more attention is now being paid to the portion of the population characterized by BP levels remaining within normal limits but approaching the 140/90 mmHg level. The 2003 ESH–ESC guidelines define BP between 130/85 and 139/89 mmHg as “high normal”, while the 2003 JNC7 guidelines introduced a new category of “prehypertension” (BP between 120/80 and 139/89 mmHg). Both these conditions affect a significant portion of a general population. Evidence is available that high normal BP is associated with an adverse risk profile and an increased risk of cardiovascular events. Therefore lifestyle changes are recommended in subjects belonging to this category and some trial data indicate that pharmacological treatment may be beneficial in high‐risk subjects with high normal BP levels. Strong evidence on the benefits of therapeutic intervention in this group is, however, still lacking.","PeriodicalId":8974,"journal":{"name":"Blood pressure. Supplement","volume":"2 ","pages":"50-2"},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08038020500424715","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25814845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Lifestyle characteristics and hypertension in the middle-aged population of Kraków. 中年人群生活方式特点与高血压的关系Kraków。
Pub Date : 2005-12-01
Andrzej Pajak, Ewa Kawalec

Hypertension affects nearly one-third of total Polish adult population. Poor control of hypertension largely contributes to high cardiovascular disease (CVD) mortality in Poland. However, satisfactory hypertension control at the national level could be beyond economical conditions. Prevention of hypertension by lifestyle modification may be one of the ways to decrease CVD population risk attributed to hypertension. The goal was to assess the relation between the chance of having hypertension and lifestyle characteristics, i.e. education, smoking, physical activity, salt consumption, ethanol consumption and body mass index (BMI) in the middle-aged population of the urban population of Kraków. A cross-sectional study of a random sample of 1157 women and 1153 men, permanent inhabitants of Kraków at age 45-64 years, was carried out by home interview followed by a visit in the clinic. There were 66% men and 56% women who had hypertension. After adjustment for age, BMI over 27.5 kg/m2 in men and over 25.0 kg/m2 in women was strongly related to hypertension. In men, odds ratio (OR) increased from 1.96 in the group with overweight (27.5 kg/m2 < or = BMI < 30.0 kg/m2) to 5.33 in the group with obesity (BMI > or = 35.0 kg/m2). In women, OR increased from 1.6 in the group with overweight (25.0 kg/m2 < or = BMI < 27.5 kg/m2) to 13.42 in the group with obesity (BMI > or = 35.0 kg/m2). In men, after adjustment for age and BMI, a higher chance of hypertension was found for binge drinkers but the result was of borderline significance (p = 0.057). In women, moderate alcohol consumption was related to lower chance of hypertension (OR = 0.72). Women who were current smokers had lower chance of hypertension (OR = 0.67). No significant relation between smoking and hypertension was found in men. After adjustment for age and BMI, there was no significant relation between hypertension and physical activity. However, both in men and in women, there was a dose effect of leisure time physical activity on the average estimate of the chance of hypertension. Education, estimate of sodium consumption and blood total cholesterol (TC) were not related to hypertension. The findings confirmed that weight control may be a strong tool for preventing hypertension and increasing physical activity and refraining from binge drinking may have a protective effect.

高血压影响了波兰近三分之一的成年人口。高血压控制不良在很大程度上导致波兰心血管疾病(CVD)死亡率高。然而,在国家层面上令人满意的高血压控制可能超出经济条件。通过改变生活方式预防高血压可能是降低高血压引起的心血管疾病人群风险的途径之一。目的是评估城市人口中中年人患高血压的几率与生活方式特征之间的关系,即教育程度、吸烟、体育活动、盐摄入量、酒精摄入量和身体质量指数(BMI)。随机抽取了1157名女性和1153名男性,年龄在45-64岁之间,是Kraków的常住居民,通过家庭访谈和诊所访问进行了横断面研究。有66%的男性和56%的女性患有高血压。在调整年龄后,男性BMI超过27.5 kg/m2和女性BMI超过25.0 kg/m2与高血压密切相关。在男性中,优势比(OR)从超重组(27.5 kg/m2 <或= BMI < 30.0 kg/m2)的1.96增加到肥胖组(BMI >或= 35.0 kg/m2)的5.33。在女性中,OR从超重组(25.0 kg/m2 <或= BMI < 27.5 kg/m2)的1.6增加到肥胖组(BMI >或= 35.0 kg/m2)的13.42。在男性中,在调整年龄和BMI后,发现酗酒者患高血压的几率更高,但结果具有临界意义(p = 0.057)。在女性中,适度饮酒与较低的高血压风险相关(OR = 0.72)。目前吸烟的女性患高血压的几率较低(OR = 0.67)。吸烟与男性高血压之间没有明显的关系。在调整了年龄和BMI之后,高血压和体力活动之间没有显著的关系。然而,在男性和女性中,休闲时间的体育活动对高血压几率的平均估计存在剂量效应。受教育程度、钠摄入量和血总胆固醇(TC)与高血压无关。研究结果证实,控制体重可能是预防高血压的有力工具,增加体育活动和避免酗酒可能具有保护作用。
{"title":"Lifestyle characteristics and hypertension in the middle-aged population of Kraków.","authors":"Andrzej Pajak,&nbsp;Ewa Kawalec","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Hypertension affects nearly one-third of total Polish adult population. Poor control of hypertension largely contributes to high cardiovascular disease (CVD) mortality in Poland. However, satisfactory hypertension control at the national level could be beyond economical conditions. Prevention of hypertension by lifestyle modification may be one of the ways to decrease CVD population risk attributed to hypertension. The goal was to assess the relation between the chance of having hypertension and lifestyle characteristics, i.e. education, smoking, physical activity, salt consumption, ethanol consumption and body mass index (BMI) in the middle-aged population of the urban population of Kraków. A cross-sectional study of a random sample of 1157 women and 1153 men, permanent inhabitants of Kraków at age 45-64 years, was carried out by home interview followed by a visit in the clinic. There were 66% men and 56% women who had hypertension. After adjustment for age, BMI over 27.5 kg/m2 in men and over 25.0 kg/m2 in women was strongly related to hypertension. In men, odds ratio (OR) increased from 1.96 in the group with overweight (27.5 kg/m2 < or = BMI < 30.0 kg/m2) to 5.33 in the group with obesity (BMI > or = 35.0 kg/m2). In women, OR increased from 1.6 in the group with overweight (25.0 kg/m2 < or = BMI < 27.5 kg/m2) to 13.42 in the group with obesity (BMI > or = 35.0 kg/m2). In men, after adjustment for age and BMI, a higher chance of hypertension was found for binge drinkers but the result was of borderline significance (p = 0.057). In women, moderate alcohol consumption was related to lower chance of hypertension (OR = 0.72). Women who were current smokers had lower chance of hypertension (OR = 0.67). No significant relation between smoking and hypertension was found in men. After adjustment for age and BMI, there was no significant relation between hypertension and physical activity. However, both in men and in women, there was a dose effect of leisure time physical activity on the average estimate of the chance of hypertension. Education, estimate of sodium consumption and blood total cholesterol (TC) were not related to hypertension. The findings confirmed that weight control may be a strong tool for preventing hypertension and increasing physical activity and refraining from binge drinking may have a protective effect.</p>","PeriodicalId":8974,"journal":{"name":"Blood pressure. Supplement","volume":"2 ","pages":"17-21"},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25814838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The scope of hypertension. 高血压的范围。
Pub Date : 2005-12-01
Renata Cífková, Kalina Kawecka-Jaszcz
{"title":"The scope of hypertension.","authors":"Renata Cífková,&nbsp;Kalina Kawecka-Jaszcz","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":8974,"journal":{"name":"Blood pressure. Supplement","volume":"2 ","pages":"3-5"},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25814940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of blood-pressure control in treated hypertensive patients in Croatia. 克罗地亚高血压治疗患者的血压控制特点。
Pub Date : 2005-12-01 DOI: 10.1080/08038020500465809
Dinko Vitezić, Thomas Burke, Jasenka Mrsić-Pelcić, Zarko Mavrić, Luka Zaputović, Gordana Zupan, Ante Simonić

The aim of our study was to investigate blood pressure (BP) control and different factors with possible influence on BP control in Croatian hypertensive patients. In this cross-sectional investigation, a representative sample of target populations (primary care physicians and patients) from different parts of Croatia was included according to the study protocol. During December 2003 and January 2004, we included, according to correctly completed questionnaires, 141 physicians and 814 hypertensive patients. A controlled BP (BP < 140/90 mmHg) in this hypertensive population treated with antihypertensive drugs was in 23% of patients. The analysis of BP control according to risk factors showed that significantly related with higher levels of systolic or diastolic BP were the age (poorer systolic BP control in patients older than 60 years), left ventricular hypertrophy, changes of the eye retina, smoking and diabetes mellitus. Furthermore, patients from towns closer to the hospital, from urban centers, with higher education and employed had significantly lower average BP. According to our results of hypertension control in Croatia, there is a need and a possibility for the improvement of the quality of hypertension care. The relationship between demographic and cardiovascular risk factors with poor BP control should be taken into account when treating patients.

本研究旨在探讨克罗地亚高血压患者的血压控制情况及可能影响血压控制的因素。在这项横断面调查中,根据研究方案纳入了克罗地亚不同地区的目标人群(初级保健医生和患者)的代表性样本。2003年12月至2004年1月,根据正确填写的问卷,我们纳入了141名医生和814名高血压患者。在接受抗高血压药物治疗的高血压人群中,23%的患者血压控制(血压< 140/90 mmHg)。根据危险因素对血压控制情况进行分析,与收缩压或舒张压升高有显著相关的因素有年龄(60岁以上患者收缩压控制较差)、左心室肥厚、视网膜改变、吸烟和糖尿病。此外,来自离医院较近的城镇、城市中心、受过高等教育和有工作的患者的平均血压明显较低。根据我们在克罗地亚控制高血压的结果,有必要并有可能提高高血压护理的质量。在治疗患者时应考虑人口统计学与血压控制不良的心血管危险因素之间的关系。
{"title":"Characteristics of blood-pressure control in treated hypertensive patients in Croatia.","authors":"Dinko Vitezić,&nbsp;Thomas Burke,&nbsp;Jasenka Mrsić-Pelcić,&nbsp;Zarko Mavrić,&nbsp;Luka Zaputović,&nbsp;Gordana Zupan,&nbsp;Ante Simonić","doi":"10.1080/08038020500465809","DOIUrl":"https://doi.org/10.1080/08038020500465809","url":null,"abstract":"<p><p>The aim of our study was to investigate blood pressure (BP) control and different factors with possible influence on BP control in Croatian hypertensive patients. In this cross-sectional investigation, a representative sample of target populations (primary care physicians and patients) from different parts of Croatia was included according to the study protocol. During December 2003 and January 2004, we included, according to correctly completed questionnaires, 141 physicians and 814 hypertensive patients. A controlled BP (BP < 140/90 mmHg) in this hypertensive population treated with antihypertensive drugs was in 23% of patients. The analysis of BP control according to risk factors showed that significantly related with higher levels of systolic or diastolic BP were the age (poorer systolic BP control in patients older than 60 years), left ventricular hypertrophy, changes of the eye retina, smoking and diabetes mellitus. Furthermore, patients from towns closer to the hospital, from urban centers, with higher education and employed had significantly lower average BP. According to our results of hypertension control in Croatia, there is a need and a possibility for the improvement of the quality of hypertension care. The relationship between demographic and cardiovascular risk factors with poor BP control should be taken into account when treating patients.</p>","PeriodicalId":8974,"journal":{"name":"Blood pressure. Supplement","volume":"2 ","pages":"33-41"},"PeriodicalIF":0.0,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08038020500465809","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25814842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
A calcium-channel blocker, benidipine, improves forearm reactive hyperemia in patients with essential hypertension. 钙通道阻滞剂苯尼地平可改善原发性高血压患者前臂反应性充血。
Pub Date : 2005-07-01 DOI: 10.1080/08038020510040612
Hirofumi Makino, Motokuni Aoki, Naotaka Hashiya, Keita Yamasaki, Hideo Shimizu, Ken Miwa, Toshio Ogihara, Ryuichi Morishita

The pathophysiological role of endothelial cells is important in the mechanism of progression of atherosclerosis and improvement of endothelial function may be important for cardiovascular morbidity. Calcium antagonists are reported to have protective effects on the endothelium in vitro and in vivo. In this clinical study, we investigated the effect of calcium antagonist, benidipine, on endothelial function in the patients with essential hypertension, which causes endothelial dysfunction. Twenty-five patients with hypertension without other risk factors for atherosclerosis were treated with monotherapy (8 mg benidipine, n=25) for 8 weeks. Blood pressure was reduced significantly. Endothelial function was evaluated using forearm blood flow by strain-gauge plethysmography after 8 weeks of treatment. Changes in vasodilator response to reactive hyperemia were significantly improved (p<0.01), while the response to nitroglycerin was not changed, suggesting the improvement of endothelial function. Moreover, we focused on hepatocyte growth factor (HGF), which is a novel angiogenic growth factor with an anti-apoptotic action on endothelial cells, and evaluated involvement of HGF in improvement of endothelial function. Serum HGF concentration in subjects treated with benidipine was significantly elevated at 8 weeks (p<0.05). Overall, these results demonstrated that benidipine improved endothelial dysfunction in patients with hypertension. Interestingly, an increase in serum HGF concentration by benidipine might contribute to the improvement of endothelial dysfunction.

内皮细胞的病理生理作用在动脉粥样硬化的进展机制中是重要的,内皮功能的改善可能对心血管疾病的发病率很重要。据报道,钙拮抗剂在体内和体外均对内皮细胞有保护作用。在本临床研究中,我们研究了钙拮抗剂苯尼地平对原发性高血压患者内皮功能的影响。25例无其他动脉粥样硬化危险因素的高血压患者接受单药治疗(8 mg苯地平,n=25),为期8周。血压明显降低。治疗8周后,用应变计体积描记法评估前臂血流内皮功能。血管扩张剂对反应性充血反应的改变显著改善(p
{"title":"A calcium-channel blocker, benidipine, improves forearm reactive hyperemia in patients with essential hypertension.","authors":"Hirofumi Makino,&nbsp;Motokuni Aoki,&nbsp;Naotaka Hashiya,&nbsp;Keita Yamasaki,&nbsp;Hideo Shimizu,&nbsp;Ken Miwa,&nbsp;Toshio Ogihara,&nbsp;Ryuichi Morishita","doi":"10.1080/08038020510040612","DOIUrl":"https://doi.org/10.1080/08038020510040612","url":null,"abstract":"<p><p>The pathophysiological role of endothelial cells is important in the mechanism of progression of atherosclerosis and improvement of endothelial function may be important for cardiovascular morbidity. Calcium antagonists are reported to have protective effects on the endothelium in vitro and in vivo. In this clinical study, we investigated the effect of calcium antagonist, benidipine, on endothelial function in the patients with essential hypertension, which causes endothelial dysfunction. Twenty-five patients with hypertension without other risk factors for atherosclerosis were treated with monotherapy (8 mg benidipine, n=25) for 8 weeks. Blood pressure was reduced significantly. Endothelial function was evaluated using forearm blood flow by strain-gauge plethysmography after 8 weeks of treatment. Changes in vasodilator response to reactive hyperemia were significantly improved (p<0.01), while the response to nitroglycerin was not changed, suggesting the improvement of endothelial function. Moreover, we focused on hepatocyte growth factor (HGF), which is a novel angiogenic growth factor with an anti-apoptotic action on endothelial cells, and evaluated involvement of HGF in improvement of endothelial function. Serum HGF concentration in subjects treated with benidipine was significantly elevated at 8 weeks (p<0.05). Overall, these results demonstrated that benidipine improved endothelial dysfunction in patients with hypertension. Interestingly, an increase in serum HGF concentration by benidipine might contribute to the improvement of endothelial dysfunction.</p>","PeriodicalId":8974,"journal":{"name":"Blood pressure. Supplement","volume":"1 ","pages":"39-44"},"PeriodicalIF":0.0,"publicationDate":"2005-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08038020510040612","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24933158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Hypertension control- A global challenge. 高血压控制——一项全球性挑战。
Pub Date : 2005-07-01 DOI: 10.1080/08037050510034266
Thomas Hedner, Krzysztof Narkiewicz, Sverre E Kjeldsen
Current estimates (1) reveal that more than a quarter of the adult world population has hypertension. An approximate one billion of people with diagnosed and undiagnosed hypertension is estimated to increase to more than 1.5 billion by 2025. The increase in hypertension prevalence will affect men as well as women in all world regions. Cardiovascular diseases now account for 30% of all deaths worldwide. Thus, with certainty, the increasing prevalence of hypertension worldwide will put further strain on the present cardiovascular pandemic. Looking back over the past century, cardiovascular disease and stroke have changed from being a minor cause of global death and disability to becoming one of the major contributors to the global burden of disease (2,3). Recent estimates by Kearney and coworkers (1) indicate that hypertension will become a greater population burden in economically developing compared with developed countries. This is because there is an ongoing epidemiological transition manifested as a decline in communicable disease and an increase in noncommunicable disease. Moreover, in the hypertensive patient population from the developing countries, the onset of cardiovascular disease is also predicted to occur at an earlier age (4). Despite the significance of hypertension with respect to overall health, control of high blood pressure in most countries is far from being optimal (5–7). In the USA, the proportion of patients achieving target blood pressure values less than 140/90 mmHg is only 34% of the hypertensive population (8). The situation is in no way better in the rest of the developed world and in the developing countries the situation is considerably worse (4). In fact, not only is hypertension treatment and followup worse, but also the medical infrastructure allowing for an early detection. Aging of the populations, urbanization and socioeconomic changes in the developing world have led to an increase in the prevalence of hypertension, with low control rates due to scarce health resources and insufficient health infrastructure. Thus prevention, detection, treatment and control of hypertension play an even more crucial role in future protection of cardiovascular disease. This scenario will be evident not only in the developed countries but also in the developing countries. In order to combat the emerging pandemic of cardiovascular disease, we need effective, welltolerated and affordable treatments. It is also evident that there is a need for educational activities for patients as well as physicians to improve compliance and adherence to therapy. In the current issue of Blood Pressure Drug Therapy Supplement, there is a focus on the clinical use and effectiveness of combination therapy in mild to moderate hypertensive patients. Koylan and coworkers (9) have studied the use of an AT1 receptor antagonist alone and in combination and Mugellini et al (10) and Agabiti Rosei et al (11) demonstrate the effective and safe use of a dihydropy
{"title":"Hypertension control- A global challenge.","authors":"Thomas Hedner,&nbsp;Krzysztof Narkiewicz,&nbsp;Sverre E Kjeldsen","doi":"10.1080/08037050510034266","DOIUrl":"https://doi.org/10.1080/08037050510034266","url":null,"abstract":"Current estimates (1) reveal that more than a quarter of the adult world population has hypertension. An approximate one billion of people with diagnosed and undiagnosed hypertension is estimated to increase to more than 1.5 billion by 2025. The increase in hypertension prevalence will affect men as well as women in all world regions. Cardiovascular diseases now account for 30% of all deaths worldwide. Thus, with certainty, the increasing prevalence of hypertension worldwide will put further strain on the present cardiovascular pandemic. Looking back over the past century, cardiovascular disease and stroke have changed from being a minor cause of global death and disability to becoming one of the major contributors to the global burden of disease (2,3). Recent estimates by Kearney and coworkers (1) indicate that hypertension will become a greater population burden in economically developing compared with developed countries. This is because there is an ongoing epidemiological transition manifested as a decline in communicable disease and an increase in noncommunicable disease. Moreover, in the hypertensive patient population from the developing countries, the onset of cardiovascular disease is also predicted to occur at an earlier age (4). Despite the significance of hypertension with respect to overall health, control of high blood pressure in most countries is far from being optimal (5–7). In the USA, the proportion of patients achieving target blood pressure values less than 140/90 mmHg is only 34% of the hypertensive population (8). The situation is in no way better in the rest of the developed world and in the developing countries the situation is considerably worse (4). In fact, not only is hypertension treatment and followup worse, but also the medical infrastructure allowing for an early detection. Aging of the populations, urbanization and socioeconomic changes in the developing world have led to an increase in the prevalence of hypertension, with low control rates due to scarce health resources and insufficient health infrastructure. Thus prevention, detection, treatment and control of hypertension play an even more crucial role in future protection of cardiovascular disease. This scenario will be evident not only in the developed countries but also in the developing countries. In order to combat the emerging pandemic of cardiovascular disease, we need effective, welltolerated and affordable treatments. It is also evident that there is a need for educational activities for patients as well as physicians to improve compliance and adherence to therapy. In the current issue of Blood Pressure Drug Therapy Supplement, there is a focus on the clinical use and effectiveness of combination therapy in mild to moderate hypertensive patients. Koylan and coworkers (9) have studied the use of an AT1 receptor antagonist alone and in combination and Mugellini et al (10) and Agabiti Rosei et al (11) demonstrate the effective and safe use of a dihydropy","PeriodicalId":8974,"journal":{"name":"Blood pressure. Supplement","volume":"1 ","pages":"4-5"},"PeriodicalIF":0.0,"publicationDate":"2005-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08037050510034266","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25286486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
期刊
Blood pressure. Supplement
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1